Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Active not recruiting 3 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 9 Breast Neoplasms 7 Neoplasms 5 Colorectal Neoplasms 5 Lung Neoplasms 4 Triple Negative Breast Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Hematopoietic and Lymphatic System Neoplasm 2 Hematologic Neoplasms 2 Depression 2 Carcinoma, Non-Small-Cell Lung 2 Anxiety Disorders 2 Alzheimer Disease 2 Advanced Malignant Solid Neoplasm 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tobacco Smoking 1 Testicular Neoplasms 1 Spondylitis, Ankylosing 1 Specific Learning Disorder 1 Smoking Cessation 1 Smoking 1 Signs and Symptoms 1 Sedentary Behavior 1 Rectal Neoplasms 1 Psoriasis 1 Pancreatic Diseases 1 Pancreatic Cyst 1 Pain 1

Interventions

Cyclophosphamide 27 fludarabine 18 Rituximab 17 obinutuzumab 11 venetoclax 9 Bendamustine Hydrochloride 9 Lenalidomide 8 zanubrutinib 6 Prednisone 6 Doxorubicin 6 Blood Specimen Collection 6 pembrolizumab 5 fludarabine phosphate 5 Biopsy 5 ibrutinib 4 glofitamab 4 Vincristine 4 Trimethoprim, Sulfamethoxazole Drug Combination 4 Exercise 4 loncastuximab tesirine 3 gamma-Globulins 3 axicabtagene ciloleucel 3 acalabrutinib 3 Temozolomide 3 Surveys and Questionnaires 3 Palliative Care 3 Mycophenolic Acid 3 Methotrexate 3 Mesna 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Methods × Clear all

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡